Search Results 1981-1990 of 21641 for platelets

1. Obeticholic Acid (OCA) In Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

   Platelet count <50 x109/L. Clinical evidence of dominant stricture as evidenced by cholangiography or other appropriate imaging modality within the 12 months ...

2. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Mayo Clinic

   Known or suspected thrombocytopenia (unless current platelet count documented above 50,000/?L) 11. Unfractionated heparin use with abnormal PTT 12. Pro ...

3. Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial) - Mayo Clinic

   Hemoglobin < 8.0 g/dl, uncorrectable INR > 3.05, or platelet count < 75,000/ml. Severe renal impairment (on chronic dialysis or estimated GFR < 30 ml/min) ...

4. Publications - Aasiya Matin, M.B.B.S. - Mayo Clinic

   Pradeep A, Falade AS, Botero JP, Chen DC, Pruthi RK, Matin A. Acquired Gray platelet syndrome as a rare hematologic complication in a case of JAK2-positive ...

5. A Study of AbGn-107 in Patients With Gastric, Colorectal, or Pancreatic Cancer - Mayo Clinic

   Platelet count ≥100 x 109/L,; Serum creatinine ≤1.5 x upper limit of normal (ULN) or a calculated creatinine clearance >60 mL/min,; Total bilirubin <1.5 x ...

6. A Study of Sporadic Angiomyolipomas Growth Kinetics While on Everolimus - Mayo Clinic

   Absolute neutrophil count ≥ 1,500/ microliter (mcL); Hemoglobin ≥10 g/dL; Platelets ≥ 100,000/ mcL; International normalized ratio (INR) ≤ 1.2 X Upper ...

7. A Study to Evaluate Brigatinib Before Brain Irradiation - Mayo Clinic

   Platelet count ≥ 75 × 10^9/L;; Hemoglobin ≥ 9 g/dL. For females of childbearing potential, have a negative pregnancy test documented prior to initiating ...

8. Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement - Mayo Clinic

   Subject has (hemoglobin) Hgb <9 g/dL, platelet count <50,000 cells/mm3 or >700,000 cells/mm3, or white blood cell count <1,000 cells/mm3. Subject requires ...

9. Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery - Mayo Clinic

   Platelets ≥ 100,000/mcL; Total bilirubin ≤ 1.5 X institutional upper limit of normal; Aspartate aminotransferase (AST) (serum glutamic oxaloacetic ...

10. Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer - Mayo Clinic

    Platelet count ≥ 100,000/mm³; Hemoglobin ≥ 8.0 g/dL (transfusion or other intervention allowed); Total bilirubin < 2 times upper limit of normal (ULN) ...